FIFLO

This brand name is authorized in Nigeria.

Active ingredients

The drug FIFLO contains one active pharmaceutical ingredient (API):

1	Tamsulosin UNII 11SV1951MR - TAMSULOSIN HYDROCHLORIDE
	Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.
	Read more about Tamsulosin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100550	Capsule	FIFLO CAPSULES CAP 400 mcg 3blisters X 10capsule	37 NF-PP-224898 FIFLO CAPSULES TAMSULOSIN HYDROCHLORIDE 400mcg Tamsulosin Hydrochloride 400mcg. Hard Gelatin Capsules Shells Size ‘2’ (brown cap and White body). Drugs Imported Products 3blistersx10capsule Prescription Only Medicine (POM) 8/25/2021 SAI SAGAR PHARMA LTD, KAARA STREET, OFF OSOLO WAY, AJAO ESTATE, LAGOS ISOLO LAGOS 8023173150 saisagarltd@gmail.com S KANT HEALTHCARE LTD, PLOT NO. 1802-1805, G.I.D.C., PHASE 111, VAPI-396195, DISTRICT VALSAD, GUJARAT, INDIA., India	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04CA02	Tamsulosin	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100550